{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:23:01Z","timestamp":1785414181544,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,30]]},"DOI":"10.7759\/cureus.39752","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T05:32:29Z","timestamp":1685511149000},"source":"Crossref","is-referenced-by-count":6,"title":["A Randomized Controlled Study Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women"],"prefix":"10.7759","author":[{"given":"Nishi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K","family":"Manjhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakanksha","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"","year":"2018","unstructured":"Hypertensive disorders. Cunningham F, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Spong CY (ed). McGraw Hill, New York City, NY; 2018. https:\/\/accessmedicine.mhmedical.com\/content.aspx."},{"key":"ref2","article-title":"Hypertensive disorders of pregnancy","volume":"3","author":"Mammaro A","year":"2009","unstructured":"Mammaro A, Carrara S, Cavaliere A, et al.. Hypertensive disorders of pregnancy. J Prenat Med. 2009, 3:1-5.","journal-title":"J Prenat Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah L","year":"2012","unstructured":"Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia\/eclampsia. Semin Perinatol. 2012, 36:56-9. 10.1053\/j.semperi.2011.09.011","journal-title":"Semin Perinatol"},{"key":"ref4","article-title":"Neonatal outcome in pre-eclamptic patients","volume":"21","author":"Ayaz A","year":"2009","unstructured":"Ayaz A, Muhammad T, Hussain SA, Habib S. Neonatal outcome in pre-eclamptic patients. J Ayub Med Coll Abbottabad. 2009, 21:53-5.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.214","article-title":"Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU high-risk aspirin study","volume":"35","author":"Moore GS","year":"2015","unstructured":"Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD. Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU high-risk aspirin study. J Perinatol. 2015, 35:328-31. 10.1038\/jp.2014.214","journal-title":"J Perinatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"12","author":"CLASP","year":"1994","unstructured":"CLASP. A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994, 12:619-29. 10.1016\/S0140-6736(94)92633-6","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005548","article-title":"Altered dietary salt for preventing pre-eclampsia, and its complications","author":"Duley L","year":"2005","unstructured":"Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev. 2005, CD005548. 10.1002\/14651858.CD005548","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.17175","article-title":"Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow","volume":"16","author":"Talari H","year":"2014","unstructured":"Talari H, Mesdaghinia E, Abedzadeh Kalahroudi M. Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow. Iran Red Crescent Med J. 2014, 16:e17175. 10.5812\/ircmj.17175","journal-title":"Iran Red Crescent Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik DL","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, et al.. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017, 377:613-22. 10.1056\/NEJMoa1704559","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2017.10.001","article-title":"An analysis of the risk factors of preeclampsia and prediction based on combined biochemical indexes","volume":"34","author":"Quan LM","year":"2018","unstructured":"Quan LM, Xu QL, Zhang GQ, Wu LL, Xu H. An analysis of the risk factors of preeclampsia and prediction based on combined biochemical indexes. Kaohsiung J Med Sci. 2018, 34:109-12. 10.1016\/j.kjms.2017.10.001","journal-title":"Kaohsiung J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2970-3","article-title":"Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial","volume":"19","author":"Lin L","year":"2018","unstructured":"Lin L, Zhu Y, Li B, Yang H. Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial. Trials. 2018, 19:608. 10.1186\/s13063-018-2970-3","journal-title":"Trials"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"26","author":"Askie LM","year":"2007","unstructured":"Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007, 26:1791-8. 10.1016\/S0140-6736(07)60712-0","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold E","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, et al.. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010, 116:402-14. 10.1097\/AOG.0b013e3181e9322a","journal-title":"Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge S","year":"2012","unstructured":"Roberge S, Villa P, Nicolaides K, et al.. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012, 31:141-6. 10.1159\/000336662","journal-title":"Fetal Diagn Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-019-01277-5","article-title":"Pilot interventional study comparing fetomaternal outcomes of 150 mg versus 75 mg aspirin starting between 11 and 14 weeks of pregnancy in patients with high risk of preeclampsia: a randomized control trial","volume":"70","author":"Kumar N","year":"2020","unstructured":"Kumar N, Das V, Agarwal A, Pandey A, Agrawal S, Singh A. Pilot interventional study comparing fetomaternal outcomes of 150 mg versus 75 mg aspirin starting between 11 and 14 weeks of pregnancy in patients with high risk of preeclampsia: a randomized control trial. J Obstet Gynaecol India. 2020, 70:23-9. 10.1007\/s13224-019-01277-5","journal-title":"J Obstet Gynaecol India"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge S","year":"2017","unstructured":"Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017, 216:110-20.e6. 10.1016\/j.ajog.2016.09.076","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14889","article-title":"Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial","volume":"46","author":"Odibo AO","year":"2015","unstructured":"Odibo AO, Goetzinger KR, Odibo L, Tuuli MG. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2015, 46:414-8. 10.1002\/uog.14889","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3924","article-title":"Effect of a small dose of aspirin on quantitative test of 24-h urinary protein in patients with hypertension in pregnancy","volume":"13","author":"Liu F","year":"2017","unstructured":"Liu F, Yang H, Li G, Zou K, Chen Y. Effect of a small dose of aspirin on quantitative test of 24-h urinary protein in patients with hypertension in pregnancy. Exp Ther Med. 2017, 13:37-40. 10.3892\/etm.2016.3924","journal-title":"Exp Ther Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000400","article-title":"The effect of aspirin on preeclampsia, intrauterine growth restriction and preterm delivery among healthy pregnancies with a history of preeclampsia","volume":"83","author":"Abdi N","year":"2020","unstructured":"Abdi N, Rozrokh A, Alavi A, et al.. The effect of aspirin on preeclampsia, intrauterine growth restriction and preterm delivery among healthy pregnancies with a history of preeclampsia. J Chin Med Assoc. 2020, 83:852-7. 10.1097\/JCMA.0000000000000400","journal-title":"J Chin Med Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/uog.218","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation","volume":"22","author":"Yu CK","year":"2003","unstructured":"Yu CK, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol. 2003, 22:233-9. 10.1002\/uog.218","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman MK","year":"2020","unstructured":"Hoffman MK, Goudar SS, Kodkany BS, et al.. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020, 395:285-93. 10.1016\/S0140-6736(19)32973-3","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.08.004","article-title":"A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China","volume":"226","author":"Lin L","year":"2022","unstructured":"Lin L, Huai J, Li B, et al.. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2022, 226:251.e1-e12. 10.1016\/j.ajog.2021.08.004","journal-title":"Am J Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson JT","year":"2014","unstructured":"Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014, 160:695-703. 10.7326\/M13-2844","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/148291-a-randomized-controlled-study-comparing-the-efficacy-of-75mg-versus-150mg-aspirin-for-the-prevention-of-preeclampsia-in-high-risk-pregnant-women","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:09Z","timestamp":1707509049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/148291-a-randomized-controlled-study-comparing-the-efficacy-of-75mg-versus-150mg-aspirin-for-the-prevention-of-preeclampsia-in-high-risk-pregnant-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.39752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}